|
Experiment
|
QTL
|
Chr
|
Nearest Marker
|
Mb
|
cM
|
CI (cM)
|
LOD
|
AE
|
Favourable Allele
|
R2
|
|---|
|
GH
|
qRCA1.1
|
1
|
Chr1_39524707
|
39.52
|
154.60
|
148.7–162.4
|
5.37
|
2.10
|
Sherpa
|
6.99
|
|
qRCA3
|
3
|
Chr3_16551946
|
16.55
|
78.23
|
71.6–81.0
|
6.10
|
−1.90
|
IRAT109
|
8.00
|
|
qRCA4
|
4
|
Chr4_30036160
|
30.03
|
101.43
|
97.0–104.0
|
12.45
|
−2.97
|
IRAT109
|
17.40
|
| | | | | | | | | | |
(36.73)
|
|
IWS19
|
qRCA1.2
|
1
|
Chr1_19340596
|
19.34
|
84.87
|
67.2–89.8
|
5.06
|
−1.73
|
IRAT109
|
5.22
|
|
qRCA1.3
|
1
|
Chr1_24919134
|
24.92
|
99.88
|
99.0–100.5
|
7.94
|
1.81
|
Sherpa
|
8.42
|
|
qRCA1.1
|
1
|
Chr1_39416289
|
39.42
|
161.41
|
150.7–164.9
|
7.66
|
1.39
|
Sherpa
|
8.10
|
|
qRCA2.1
|
2
|
Chr2_27972049
|
27.97
|
122.53
|
119.0–133.2
|
4.64
|
1.36
|
Sherpa
|
4.76
|
|
qRCA2.2
|
2
|
Chr2_30400561
|
30.40
|
134.12
|
131.4–135.9
|
9.48
|
−1.92
|
IRAT109
|
10.22
|
|
qRCA4
|
4
|
Chr4_29775386
|
29.78
|
98.97
|
97.0–99.9
|
20.13
|
−2.47
|
IRAT109
|
24.18
|
|
qRCA11
|
11
|
Chr11_19591983
|
19.59
|
76.31
|
73.4–83.3
|
5.74
|
−1.16
|
IRAT109
|
5.96
|
| | | | | | | | | | |
(49.72)
|
|
WW20
|
qRCA1.1
|
1
|
Chr1_39524707
|
39.52
|
153.61
|
148.7–162.4
|
9.35
|
3.68
|
Sherpa
|
10.22
|
|
qRCA3
|
3
|
Chr3_16551946
|
16.55
|
76.34
|
44.6–100.3
|
3.31
|
−1.86
|
IRAT109
|
4.12
|
|
qRCA4
|
4
|
Chr4_30366129
|
30.37
|
102.14
|
99.0–104.6
|
15.51
|
−4.29
|
IRAT109
|
21.11
|
| | | | | | | | | | |
(38.31)
|
|
IWS20
|
qRCA1.2
|
1
|
Chr1_23120475
|
23.12
|
85.86
|
78.0–90.8
|
5.40
|
−2.44
|
IRAT109
|
5.42
|
|
qRCA1.3
|
1
|
Chr1_24919134
|
24.92
|
99.88
|
99.0–100.5
|
8.84
|
2.63
|
Sherpa
|
9.18
|
|
qRCA1.1
|
1
|
Chr1_39416289
|
39.42
|
161.41
|
152.6–164.9
|
8.90
|
1.97
|
Sherpa
|
9.25
|
|
qRCA2.1
|
2
|
Chr2_27972049
|
27.97
|
122.53
|
119.0–133.2
|
4.30
|
1.71
|
Sherpa
|
4.27
|
|
qRCA2.2
|
2
|
Chr2_30400561
|
30.40
|
134.12
|
131.4–135.9
|
8.79
|
−2.42
|
IRAT109
|
9.12
|
|
qRCA4
|
4
|
Chr4_29775386
|
29.78
|
98.97
|
97.0–99.9
|
20.70
|
−3.28
|
IRAT109
|
24.28
|
|
qRCA11
|
11
|
Chr11_20763446
|
20.76
|
82.62
|
73.4–84.0
|
5.02
|
−1.38
|
IRAT109
|
5.03
|
| | | | | | | | | | |
(51.22)
|
- Mb - physical map position of each marker based on the Nipponbare sequence at RAP database (http://rapdb.dna.affrc.go.jp/); CI- bayesian credible confidence intervals in centiMorgan (cM); AE: additive effect of the allele from IRAT109 compared with that from the recipient line, Sherpa; R2 - percentage of the genotypic variance explained by each QTL. Numbers in parentheses indicate percentage of the variance explained by multiple QTL; GH - Glasshouse Experiment; IWS19 - intermittent water stress 2019 experiment, WW20 - well-watered 2020 experiment, and IWS20 - intermittent water stress 2020 experiment
